BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7025019)

  • 1. Cytoprotection by sulglycotide: prevention of gastric necrosis in rat.
    Niada R; Malandrino S; Nardi GF; Mantovani M; Prino G; Omini C; Berti F
    Pharmacol Res Commun; 1981 Jul; 13(7):695-704. PubMed ID: 7025019
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulglycotide displays cytoprotective activity in rat gastric mucosa.
    Niada R; Mantovani M; Prino G; Omini C; Berti F
    Int J Tissue React; 1983; 5(3):285-8. PubMed ID: 6360935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoprotective activity of deboxamet: a possible interference with prostaglandin and prostacyclin metabolism in rat gastric mucosa.
    Franzone JS; Cirillo R; Cravanzola C
    Int J Tissue React; 1988; 10(3):149-58. PubMed ID: 3066776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sulglycotide on endogenous prostaglandin synthesis in human antral mucosa.
    Calabrò A; Orsini B; Milani S; Psilogenis M; Surrenti C
    Pharmacol Res; 1992 Dec; 26(4):403-7. PubMed ID: 1294942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of stress and indomethacin, carbenoxolone, salbutamol, metiamide, zolimidine and CF19415 on rat gastric mucus.
    Green AP; Lander JE; Turner DH
    J Pharm Pharmacol; 1981 Jun; 33(6):348-52. PubMed ID: 6115004
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-ulcer activity of carbenoxolone and ISF 3401 on PGE2 release in rat gastric mucosa.
    Franco L; Manara P; Erbetti I; Velo GP
    Pharmacol Res; 1993; 27(2):141-50. PubMed ID: 8474959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiulcer and gastroprotective effects of quercetin: a gross and histologic study.
    Alarcón de la Lastra C; Martín MJ; Motilva V
    Pharmacology; 1994 Jan; 48(1):56-62. PubMed ID: 8309988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of escin against indomethacin-induced gastric ulcer in mice.
    Wang T; Zhao S; Wang Y; Yang Y; Yao L; Chu L; Du H; Fu F
    Toxicol Mech Methods; 2014 Dec; 24(8):560-6. PubMed ID: 25137224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement in gastric mucosal epidermal growth factor receptor expression by sulglycotide.
    Slomiany BL; Piotrowski J; Czajkowski A; Murty VL; Majka J; Slomiany A
    Biochem Mol Biol Int; 1994 May; 33(2):229-34. PubMed ID: 7951043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiulcer effect of naringin on gastric lesions induced by ethanol in rats.
    Martín MJ; Marhuenda E; Pérez-Guerrero C; Franco JM
    Pharmacology; 1994 Sep; 49(3):144-50. PubMed ID: 7972328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by sulglycotide.
    Slomiany BL; Piotrowski J; Slomiany A
    Gen Pharmacol; 1999 Feb; 32(2):251-7. PubMed ID: 10188628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-PGDH inhibitors: the antiulcer effects of carbenoxolone, pioglitazone and verapamil in indomethacin induced peptic ulcer rats.
    Moustafa YM; El-Azab MF; Fouda A
    Eur Rev Med Pharmacol Sci; 2013; 17(15):2000-9. PubMed ID: 23884819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying.
    Robert A; Olafsson AS; Lancaster C; Zhang WR
    Life Sci; 1991; 48(2):123-34. PubMed ID: 1825231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of sulglycotide on human gastric mucosa exposed to taurocholic acid.
    Corinaldesi R; Zurita J; Cenedese A; Stanghellini V; Cavalli G; Paparo G; Barbara L
    Int J Clin Pharmacol Res; 1987; 7(2):101-4. PubMed ID: 3583492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients.
    Bianchi Porro G; Montrone F; Petrillo M; Caruso I; Ardizzone S
    Scand J Gastroenterol; 1993 Oct; 28(10):875-8. PubMed ID: 8266016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of stobadine on indomethacin- and ethanol-induced stomach lesions and gastric secretion.
    Mirossay L; Kohút A
    Physiol Res; 1991; 40(4):437-40. PubMed ID: 1811722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal laminin receptor: effect of sulglycotide.
    Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
    Gen Pharmacol; 1993 Nov; 24(6):1467-72. PubMed ID: 8112522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Helicobacter pylori glycosulfatase activity towards human gastric sulfomucin by a gastroprotective agent, sulglycotide.
    Murty VL; Piotrowski J; Czajkowski A; Slomiany A; Slomiany BL
    Gen Pharmacol; 1993 Nov; 24(6):1463-6. PubMed ID: 8112521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastro-protective effect of methanol extract of Ficus asperifolia bark on indomethacin-induced gastric ulcer in rats.
    Raji Y; Oyeyemi WA; Shittu ST; Bolarinwa AF
    Niger J Physiol Sci; 2011 Nov; 26(1):43-8. PubMed ID: 22314986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docosahexaenoic acid, an omega-3 polyunsaturated acid protects against indomethacin-induced gastric injury.
    Pineda-Peña EA; Jiménez-Andrade JM; Castañeda-Hernández G; Chávez-Piña AE
    Eur J Pharmacol; 2012 Dec; 697(1-3):139-43. PubMed ID: 23063544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.